Literature DB >> 6199458

Identification of infected cell-specific monoclonal antibodies and their role in host resistance to ocular herpes simplex virus type 1 infection.

J T Rector, R N Lausch, J E Oakes.   

Abstract

Monoclonal antibodies 35S and 55S, specific for herpes simplex virus type 1 (HSV-1) glycoproteins gB and gD respectively, were found to react with infected cell membranes but not cell-free virions. This indicates that the spectrum of viral determinants detectable on the infected cell surface is not identical to that detectable on the virion envelope. The monoclonal antibody 35S could promote recovery from ocular HSV-1 infection in mice. Thus, antibody reactive with infective cell-specific determinants can play a significant role in host resistance to HSV-1 infection.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6199458     DOI: 10.1099/0022-1317-65-3-657

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  7 in total

1.  Localization of discontinuous epitopes of herpes simplex virus glycoprotein D: use of a nondenaturing ("native" gel) system of polyacrylamide gel electrophoresis coupled with Western blotting.

Authors:  G H Cohen; V J Isola; J Kuhns; P W Berman; R J Eisenberg
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

2.  Localization of epitopes of herpes simplex virus type 1 glycoprotein D.

Authors:  R J Eisenberg; D Long; M Ponce de Leon; J T Matthews; P G Spear; M G Gibson; L A Lasky; P Berman; E Golub; G H Cohen
Journal:  J Virol       Date:  1985-02       Impact factor: 5.103

3.  Fine mapping of antigenic site II of herpes simplex virus glycoprotein D.

Authors:  V J Isola; R J Eisenberg; G R Siebert; C J Heilman; W C Wilcox; G H Cohen
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

4.  Analysis of the role of antibody-dependent cellular cytotoxic antibody activity in murine neonatal herpes simplex virus infection with antibodies to synthetic peptides of glycoprotein D and monoclonal antibodies to glycoprotein B.

Authors:  S Kohl; N C Strynadka; R S Hodges; L Pereira
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

5.  Recombinant human Fab to glycoprotein D neutralizes infectivity and prevents cell-to-cell transmission of herpes simplex viruses 1 and 2 in vitro.

Authors:  R Burioni; R A Williamson; P P Sanna; F E Bloom; D R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

6.  Identification of distinct antigenic determinants on Semliki Forest virus by using monoclonal antibodies with different antiviral activities.

Authors:  W A Boere; T Harmsen; J Vinjé; B J Benaissa-Trouw; C A Kraaijeveld; H Snippe
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

7.  Highly Efficacious Novel Vaccine, Humoral Immunity, and Ocular Herpes Simplex Virus 1: Reality or Myth?

Authors:  Homayon Ghiasi
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.